Browse EX-10 agreements

July 13, 2026

Eric M. Mellinger

[Intentionally omitted.]

[Intentionally omitted.]

Dear Eric,

Spire Global Subsidiary, Inc. (the “Company”) is pleased to offer you employment on the terms of this letter agreement (the “Agreement”):

1.

Position and Start Date. Your job title will initially be Chief Commercial Officer of Spire Global, Inc., and you will be working in our Tyson’s Corner, VA office. You will initially report to Theresa Condor, Chief Executive Officer. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time) that would create a conflict of interest with the Company. By signing this Agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company. You and the Company anticipate that your initial date of employment (your “Start Date”) will be August 3, 2026.

2.

Cash Compensation.

(a)

…

TRANSITION SERVICES AGREEMENT

This Transition Services Agreement (this “Agreement”) is made and entered into by and between Sam Hinrichsen (“Hinrichsen”) and Lindsay Corporation, a Delaware corporation (the “Company”) to become effective on the Effective Date (as defined in Section 14), on the terms and subject to the conditions set forth herein.

RECITALS

WHEREAS, Hinrichsen currently serves as Senior Vice President and Chief Financial Officer of the Company, but has notified the Company of his intention to leave the Company for personal reasons, with his employment to terminate effective August 31, 2026;

WHEREAS, in order to assure access to Hinrichsen’s unique and valuable services and an effective leadership transition, the Company desires to retain Hinrichsen to provide transition services for a specified transition period on the terms and conditions set forth herein; and

WHEREAS, Hinrichsen agrees to provide transition services to the Company during the specified transition period on the terms and conditions set forth herein;

…

Execution Version

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

GM FINANCIAL CONSUMER AUTOMOBILE RECEIVABLES TRUST 2026-3,

Issuer

AMERICREDIT FINANCIAL SERVICES, INC.

D/B/A GM FINANCIAL,

Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,

Asset Representations Reviewer

Dated as of July 15, 2026

---

TABLE OF CONTENTS

| | | | | | | | | ------------------------------------------------------- | - | ----------------------------------------------------------- | : | - | -: | - | | | | | | | | | | ARTICLE I DEFINITIONS | | | | | 1 | | | Section 1.1. | | Definitions | | | 1 | |

…

Execution Version

**PURCHASE AGREEMENT **

**between **

**AFS SENSUB CORP. **

**Purchaser **

**and **

**AMERICREDIT FINANCIAL SERVICES, INC. **

**D/B/A GM FINANCIAL **

**Seller **

**Dated as of July 15, 2026 **

---

**TABLE OF CONTENTS **

| | | | | | | | | ----------------------------------------------------------------------------- | - | --------------------------------------------------------------------------- | : | :---: | -----: | ----- | | | | | | | | | | | | | | Page | | |

…

DEEP FISSION, INC.

2025 Equity Incentive Plan, as Amended

	1.	General

(a)            Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

(b)            Available Awards. The Plan provides for the grant of the following Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock Options; (iii) SARs; (iv) Restricted Stock Awards; (v) RSU Awards; (vi) Performance Awards; and (vii) Other Awards.

(c)            Adoption Date; Effective Date. The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective Date.

…

SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of July 15, 2026, is between HUACHEN AI PARKING MANAGEMENT TECHNOLOGY HOLDING CO., LTD, an exempted company incorporated under the laws of the Cayman Islands, with headquarters located at 101 Cecil Street, #13-05 Tong Eng Building, Singapore 069533 (the “Company”), and each of the investors identified on the signature pages hereto (each a “Buyer” and collectively the “Buyers”).

WITNESSETH

WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to each Buyer, and each Buyer shall purchase from the Company, Class A Ordinary Shares of the Company (the “Class A Ordinary Shares”), par value US$0.0000375 per share, at a purchase price of US$1.552 per share (the “Purchase Price”) in the respective amounts set forth on each Buyer’s signature page hereof (the “Subscription Amount”);

** **

WHEREAS, The Class A Ordinary Shares are collectively referred to herein as the “Securities”; and

…

EXECUTION COPY

FOURTH AMENDMENT
TO SENIOR SECURED REVOLVING CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO SENIOR SECURED REVOLVING CREDIT AGREEMENT, dated as of July 14, 2026 (this “Amendment”), to the Existing Credit Agreement (capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in Article I) is among BAIN CAPITAL PRIVATE CREDIT, a Delaware statutory trust (the “Borrower”), solely with respect to Section 5.12herein, the SUBSIDIARY GUARANTORS party hereto, the LENDERS and ISSUING BANKS party hereto and SUMITOMO MITSUI BANKING CORPORATION, as Administrative Agent (the “Administrative Agent”) and, solely with respect to Section 5.11herein, as Collateral Agent (the “Collateral Agent”).

W I T N E S S E T H:

…

CORPORATE INTEGRITY AGREEMENT BETWEEN THE

OFFICE OF INSPECTOR GENERAL OF THE

DEPARTMENT OF HEALTH AND HUMAN SERVICES AND

EYEPOINT INC.

I.

PREAMBLE

EyePoint Inc. and all subsidiaries and any additional affiliated entities owned, controlled, or operated by EyePoint Inc. including those that may be created during the term of this CIA (collectively, “Entity”) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements) and written directives of the Food and Drug Administration (FDA requirements). Contemporaneously with this CIA, Entity is entering into a Settlement Agreement with the United States.

II.

EFFECTIVE DATE, TERM, AND DEFINITIONS

A.

…

SETTLEMENT AGREEMENT

This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services (“OIG‑HHS”) and the Defense Health Agency (“DHA”), acting on behalf of the TRICARE Program, (collectively, the “United States”); EyePoint, Inc. (“EyePoint”); and AFCE LLC (hereafter collectively referred to as “the Parties”), through their authorized representatives.

RECITALS

A. EyePoint, Inc. (formerly EyePoint Pharmaceuticals, Inc.) is a pharmaceutical company headquartered in Massachusetts and incorporated under the laws of Delaware. EyePoint is a bio-therapeutic company which develops and commercializes treatments for eye diseases.

…

REGISTRATION RIGHTS AGREEMENT

among

CSQUARE, INC.

AND

THE HOLDERS PARTY HERETO

DATED July 17, 2026

TABLE OF CONTENTS

Page

ARTICLE I DEFINITIONS		1
Section 1.1	Definitions	1
ARTICLE II DEMAND AND SHELF REGISTRATION		5

…

STOCKHOLDERS AGREEMENT

by and among

CSQUARE, INC.

and

THE OTHER PARTIES HERETO

Dated as of July 17, 2026

TABLE OF CONTENTS

Page

Article** I** INTRODUCTORY MATTERS		1
Section 1.1	Defined Terms	1
Section 1.2	Construction	4
Article** II** BOARD OF DIRECTORS		5
Section 2.1	Election of Directors	5

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of [___], 2026, between Valion Bio, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.
DEFINITIONS

…